Steven Cohen’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History

Steven Cohen’s Portfolio FNCH Stock Details FNCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-48	Closed	-$23K	–	1230
2021 Q1	$23K	Buy	+48	New	+$24.4K	﹤0.01%	925

Other funds holding FNCH

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

TRB Advisors New York $233M AUM 14.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Aperture Investors New York $1.11B AUM 81.44% 1-Year Est. Return

Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return

MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Steven Cohen's FNCH Position: Q2 2021 in Review

Steven Cohen sold out of Finch Therapeutics Group, Inc. Common Stock (FNCH) in Q2 2021, closing a stake of 48 shares — an estimated $23K sold.

Steven Cohen first reported a position in FNCH in Q1 2021 and held it in 1 quarter. The position peaked at $23K in Q1 2021. 45 funds tracked by Wall St. Rank hold FNCH as of Q2 2021.

Steven Cohen reported no remaining Finch Therapeutics Group, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Steven Cohen sold 48 Finch Therapeutics Group, Inc. Common Stock shares in Q2 2021, an estimated $23K.
Steven Cohen first reported a position in Finch Therapeutics Group, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
Steven Cohen's Finch Therapeutics Group, Inc. Common Stock position peaked at $23K in Q1 2021.
45 funds tracked by Wall St. Rank held Finch Therapeutics Group, Inc. Common Stock as of Q2 2021.

Based on Point72 Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.